期刊文献+

肝肾综合征329例预后分析 被引量:16

Prognostic analysis of 329 cases of hepatorenal syndrome
下载PDF
导出
摘要 目的分析肝肾综合征(hepatorenal syndrome,HRS)的诱因、临床特点及预后,以提高对本病的认识水平。方法对2004年1月-2009年7月解放军第三○二及解放军第二六○医院收治的329例HRS患者的临床资料进行回顾性分析。主要分析指标有血清Na+、Cr、ALB、PTA和终末期肝病模型(modelforend-stageliver disease,MELD)评分。结果 HRS多发于40~60岁男性,主要发生于乙型肝炎所致的肝硬化、慢性重型肝炎患者。感染(自发性细菌性腹膜炎)及消化道出血为常见诱因。配对t检验显示,HRS发生前后患者血清Na+、Cr、ALB、PTA和MELD评分的变化显著(P均<0.05)。本组患者中好转仅16例(4.86%)。结论 HRS预后极差,好转率<5%;MELD评分变化对HRS患者预后具有一定的预测价值。 Objective To analyze the etiology, clinical features and prognosis of hepatorenal syndrome (HRS) so as to improve clinicians' understanding of HRS. Methods Clinical data of 329 patients with HRS admitted to 302 and 260 hospital of PLA from Jan. 2004 to July 2009 were retrospectively reviewed. The main markers observed were serum sodium, creatinine (Cr), albumin (ALB), plasma prothrombin activity (PTA) and model for end-stage liver disease (MELD) score. Results HRS was more prevalent among males aged 40-60 and patients with cirrhosis and chronic severe hepatitis due to hepatitis B. HRS was mainly caused by infection (including spontaneous bacterial peritonitis) and alimentary tract hemorrhage. Paired-samples t test showed significant differences in serum sodium, Cr, ALB, PTA and MELD score before and after the occurrence of HRS (P 〈0.05). Only 16 patients (4.86%) with HRS improved. Conclusions The HRS patients have poor prognosis with the improvement rate of less than 5%. The variation in MELD score may serve as a useful predictor in evaluating the prognosis of HRS patients.
出处 《传染病信息》 2010年第2期87-89,共3页 Infectious Disease Information
基金 国家"十一五"科技重大专项(2008ZX10002-005-6)
关键词 肝肾综合征 肝功能衰竭 治疗结果 hepatorenal syndrome liver failure treatment outcome
  • 相关文献

参考文献15

  • 1熊号峰,贾继东.肝衰竭合并肝肾综合征的研究进展[J].传染病信息,2009,22(5):269-272. 被引量:18
  • 2Salerno F, Gerbes A, Gin,s P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [J]. Gut, 2007, 56 (9):1310-1318.
  • 3唐锡尔.肝肾综合征诊治现状[J].现代实用医学,2008,20(5):333-335. 被引量:1
  • 4Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cin'hosis[J]. J Hepatol, 2005, 48(Suppl 1):S93-S103.
  • 5Angeli P, Guarda S, Fasolato S, et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost[J]. Aliment Pharmacol Ther, 2006, 23(1):75-84.
  • 6吕爱云,江河清,王玉洲.32例肝肾综合征原因分析[J].传染病信息,2005,18(1):36-37. 被引量:1
  • 7De las Heras D, Fernandez J, Gin,s P, et al.Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis[J]. Hepatology, 2003, 38(2):452- 459.
  • 8Fernandez J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis[J]. Gastroenterology, 2007, 133(3): 818-824.
  • 9李定国,汪保灿.关注肝肾综合征研究新进展[J].胃肠病学和肝病学杂志,2009,18(4):299-301. 被引量:12
  • 10周晓琳,覃慧敏,谢迎春,陈一东,冯芳,叶丰,谭宏祜.肝硬化腹腔积液并发肝肾综合征的高危因素探讨[J].中国综合临床,2007,23(6):508-510. 被引量:6

二级参考文献63

共引文献57

同被引文献171

引证文献16

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部